WASHINGTON — Marty Makary, commissioner of the U.S. Food and Drug Administration (FDA), is resigning from his role, according to an administration source with direct knowledge of the decision. Kyle Diamantas, the agency’s top food regulator, will assume the position of acting commissioner.
Makary’s tenure lasted just over one year. Neither the White House nor spokespeople for Makary or Health and Human Services Secretary Robert F. Kennedy Jr. responded to requests for comment.
A faction within the Department of Health and Human Services (HHS) had grown dissatisfied with Makary’s leadership and had been exploring avenues to remove him for several months, according to sources cited by STAT.
Speculation about Makary’s potential exit intensified on Friday, following reports in The Wall Street Journal and other outlets that President Donald Trump planned to dismiss him. HHS officials had already begun evaluating potential replacements for Makary, sources familiar with the matter told STAT.
Related articles
FDA Drug Center Acting Director Tracy Beth Høeg Departs Amid Leadership Changes
WASHINGTON — The acting director of the Food and Drug Administration’s drug center, Tracy Beth Høeg, is leaving the agency, according to three sources...
Robert F. Kennedy Jr. Balances Vaccine Skepticism with Ohio Outreach Tour
Here in Washington, we’ve been hearing about tensions between the White House and one of its most controversial — but, at least in some circles, most...
Kratom Use Surges in the US: Rising Addiction and Mental Health Concerns
A national study of kratom use in the US found rising popularity among young adults, and it is linked to addiction and mental health issues, according...
UK Political Shake-Up Could Reshape Global Drug Pricing Policies
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Congrats on...
U.S. Pressures Germany on Drug Prices Amid FDA Restructuring Concerns
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about we...
Mail-Order Abortion Pills Remain Legal Amid Legal Uncertainty
In a discussion about the best fruits, my STAT colleague Alexa Lee and I agreed that peaches have been mid in recent years. Is this just a New York Ci...
FDA Rejects Melanoma Drug RP1 Amid Leadership Controversy Under Makary
The FDA’s recent decision to withhold approval of a new skin cancer treatment fell like a hammer on doctors who treat melanoma and patients who saw th...
Why Alcohol Remains Overlooked Despite Its Deadly Toll in the U.S.
Alcohol kills more Americans than any other drug by a wide margin. But discussions about substance use epidemics in the U.S. are usually centered arou...